ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!ZOM Company Profile and Key Details
Zomedica Corp.
ZOM Stock Price Chart
Stock Price Today
Zomedica Corp. (ZOM) stock declined over -0.66%, trading at $0.12 on AMEX, down from the previous close of $0.12. The stock opened at $0.12, fluctuating between $0.12 and $0.12 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Company Information
| Employees | 144 |
| Beta | 1.03 |
| Sales or Revenue | $25.19M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Zomedica Corp. (AMEX: ZOM) stock price is $0.12 in the last trading session. During the trading session, ZOM stock reached the peak price of $0.12 while $0.12 was the lowest point it dropped to. The percentage change in ZOM stock occurred in the recent session was -0.66% while the dollar amount for the price change in ZOM stock was -$0.00.
The AMEX listed ZOM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Zomedica Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Evan St. Peter
Vice President of Technology Innovation
Mr. Anthony K. Blair
Chief Operating Officer
Ms. Karen DeHaan-Fullerton J.D.
Gen. Counsel, Chief Counsel & Corporation Sec.
Dr. Stephanie Laine Morley D.V.M., DVM
Consultant
Dr. William Carpenter MacArthur
Consultant
Ms. Kristin Domanski
Vice President of HR
Mr. Larry C. Heaton II
Pres, Chief Executive Officer & Director
Ms. Nicole Westfall
Vice President of Marketing
Mr. Adrian Lock
Vice President, GM & Head of Sales
Ms. Ann Marie Cotter CPA
Chief Financial Officer
Mr. Robert W. DiMarzo
Consultant
Mr. Peter L. Donato BSBA, M.B.A.
Chief Financial Officer
Mr. Greg Blair
Vice President of Bus. Devel. & Strategic Planning
Ms. Karen L. DeHaan-Fullerton J.D.
Chief Counsel & Corporation Sec.
ZOM's closing price is 2.39% higher than its 52-week low of $0.12 where as its distance from 52-week high of $0.20 is -38.56%.
Number of ZOM employees currently stands at 144.
Official Website of ZOM is: https://www.zomedica.com
ZOM could be contacted at phone 734 369 2555 and can also be accessed through its website. ZOM operates from 100 Phoenix Drive, Ann Arbor, MI 48108, United States.
ZOM stock volume for the day was 3.73M shares. The average number of ZOM shares traded daily for last 3 months was 5.45M.
The market value of ZOM currently stands at $117.40M with its latest stock price at $0.12 and 979.95M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com